Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation
about
New Trends in Aryl Hydrocarbon Receptor BiologyTargeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyAnti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisSignaling network map of the aryl hydrocarbon receptorBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistRecombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cellsNovel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer CellsThe role of AhR in autoimmune regulation and its potential as a therapeutic target against CD4 T cell mediated inflammatory disorderThe aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells.Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors.CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptorCancer-promoting and Inhibiting Effects of Dietary Compounds: Role of the Aryl Hydrocarbon Receptor (AhR)In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasisIntersection of AHR and Wnt signaling in development, health, and disease.Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways.The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines.Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancerAryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα proteinThe role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4Activation of the aryl hydrocarbon receptor AhR Promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4.p23 co-chaperone protects the aryl hydrocarbon receptor from degradation in mouse and human cell lines.Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cellsAryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer CellsPhemindole, a Synthetic Di-indole Derivative Maneuvers the Store Operated Calcium Entry (SOCE) to Induce Potent Anti-Carcinogenic Activity in Human Triple Negative Breast Cancer Cells.6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer CellsThe AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.Mechanoresponsive stem cells to target cancer metastases through biophysical cues.Grouping 34 Chemicals Based on Mode of Action Using Connectivity Mapping.The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.SUMOylation of AhR modulates its activity and stability through inhibiting its ubiquitination.Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
P2860
Q26744482-A7C366A9-3E62-4106-BB83-4F6070E78F0CQ26863340-A1F466ED-B2A3-42A2-BCA7-87E61F25728AQ28260352-3E4C9D8C-E261-4A96-8CE3-7DD2A8B68E03Q28388257-88AF5C67-D6A8-4542-9535-235A67CB95E8Q28396094-630A3CF5-E34A-400F-B8E5-02B1E83C877DQ28475994-64AA5E95-B00F-4400-BCD9-217070EAE96DQ28478701-CFFA9288-E21A-46DB-9698-AAA71A83C397Q28554754-25A5965F-6C9A-41C1-9611-7D113DAADD76Q28655676-567EA688-BBFD-4C24-ADB1-72CC93AFB4E8Q33695032-7A0FB744-161F-469A-BD80-277ED5574B40Q34118866-5B8880F3-6D3E-42C0-92DF-9CA4ADC612FCQ34131886-20457A9C-14D9-41F2-AB83-07F26F012186Q34231307-B036CDA0-B227-4C8C-95FF-F623B28BB970Q34360082-B0B35F75-A9C2-4CF8-A19F-EB833510196FQ34485137-F10B2473-1CE0-4C35-9272-26EF06EC46CDQ34486670-9CB7384D-DBF9-4351-B4E5-A472D69B79DDQ34778661-D6F6D886-4A9F-4ED3-A458-1E4989F97DD8Q35297936-97CD22AB-9C94-495A-BA20-D3358E22D9A1Q35551010-B970C74A-A199-40DC-BDE5-036589D40CF6Q35667189-48F1AEF4-EC12-4C92-A396-94DAF53E4A27Q35907414-12163E18-828A-4B0A-8289-D10358AEC250Q35960211-DA866033-DAC6-4444-8C70-8BDDB875D6DCQ36069377-C6B5B6ED-A7DE-4B7C-A91F-029A9082702FQ36080617-4ECD3DA0-F4A3-4BBD-A89F-97D20720CE01Q36161914-7E4B8498-9D79-4F80-84AF-A06D169A1046Q36208050-21CCC10E-3F0E-44A7-8F0E-C37631AF5C82Q36325693-D280CE7D-088E-4B7B-82A5-1C0779A6428CQ36863681-890E7C2D-B0E4-4E03-A76E-3EE09110EAACQ36958464-A5AD7104-E20F-4F89-A3C5-945EE1423950Q37108803-CE7AC8B8-5CA5-4DD8-B185-BB5BD214F8C6Q37194722-27C06D0B-92BF-4A68-BAB9-F1F2C2E513DDQ37357710-32732E96-C3C8-4682-AF20-AFEE5F6C3BDFQ38173701-A529D4DD-3971-4EC7-9F8B-AFB20E14B18CQ38651379-635E9C57-8345-4C65-856B-8C6ECBF8AF7DQ38782465-780D3072-3792-4AEE-B9A9-9A646F449A2CQ39127681-2803E2CE-3C83-4606-AF58-BDB963F690DAQ39309007-4299B7E1-D9E8-407A-A3EF-C8EFFD6F6B5FQ39365756-DE4648CD-4B93-4504-BB8F-32B5C412736BQ42450380-358F19DC-E5C2-4BDB-AA9A-CDB1927B9269Q47213795-306EBDB8-05BC-4759-BEC9-DC5317A509AC
P2860
Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activation of the aryl-hydroca ...... st cancer cell differentiation
@ast
Activation of the aryl-hydroca ...... st cancer cell differentiation
@en
type
label
Activation of the aryl-hydroca ...... st cancer cell differentiation
@ast
Activation of the aryl-hydroca ...... st cancer cell differentiation
@en
prefLabel
Activation of the aryl-hydroca ...... st cancer cell differentiation
@ast
Activation of the aryl-hydroca ...... st cancer cell differentiation
@en
P2093
P2860
P356
P1476
Activation of the aryl-hydroca ...... st cancer cell differentiation
@en
P2093
Dmitri Kazmin
Donald P McDonnell
Julie M Hall
Melissa A Barhoover
William F Greenlee
P2860
P304
P356
10.1210/ME.2009-0346
P577
2009-12-23T00:00:00Z